Neoantigens: promising targets for cancer therapy.

Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L. · 2023

Read Neoantigens: promising targets for cancer therapy. by Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9816309.txt.

Introduction

Xie and co-authors review neoantigens as promising targets for cancer therapy. Neoantigens are new flags that tumor cells alone display. They arise from changes found only in the tumor. Mutation, splicing errors, and viral parts can all create them.

The immune system reads these flags as fully foreign. No tolerance training ever taught it to spare them. That makes them clean targets for immune attack. Sequencing and computing now find them quickly in patients. The review sorts neoantigens by their source changes. Genome, RNA, and protein level origins each get covered. Finding, predicting, and testing real targets is walked through. Vaccines and cell therapies built on them are surveyed. Antibody approaches join the clinical picture as well. The markers may also forecast survival and drug response. Hurdles in making each therapy personal close the tour.

Catalog record

CREATORXie N, Shen G, Gao W, Huang Z, Huang C, Fu L.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE256 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9816309

Browse the full library · About the Tower of Babel